Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya – a cohort study

Authors: Florence Nafula Okwara, John Paul Oyore, Fred Nabwire Were, Samson Gwer

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Sub-Saharan Africa continues to document high pediatric tuberculosis (TB) burden, especially among the urban poor. One recommended preventive strategy involves tracking and isoniazid preventive therapy (IPT) for children under 5 years in close contact with infectious TB. However, sub-optimal effectiveness has been documented in diverse settings. We conducted a study to elucidate correlates to IPT strategy failure in children below 5 years in high burden settings.

Methods

A prospective longitudinal cohort study was done in informal settlings in Nairobi, where children under 5 years in household contact with recently diagnosed smear positive TB adults were enrolled. Consent was sought. Structured questionnaires administered sought information on index case treatment, socio-demographics and TB knowledge. Contacts underwent baseline clinical screening exclude TB and/or pre-existing chronic conditions. Contacts were then put on daily isoniazid for 6 months and monitored for new TB disease, compliance and side effects. Follow-up continued for another 6 months.

Results

At baseline, 428 contacts were screened, and 14(3.2%) had evidence of TB disease, hence excluded. Of 414 contacts put on IPT, 368 (88.8%) completed the 1 year follow-up. Operational challenges were reported by 258(70%) households, while 82(22%) reported side effects. Good compliance was documented in 89% (CI:80.2–96.2). By endpoint, 6(1.6%) contacts developed evidence of new TB disease and required definitive anti-tuberculosis therapy. The main factor associated with IPT failure was under-nutrition of contacts (p = 0.023).

Conclusion

Under-nutrition was associated with IPT failure for child contacts below 5 years in high burden, resource limited settings. IPT effectiveness could be optimized through nutrition support of contacts.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016. World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016.
2.
go back to reference Van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in South Africa: burden and risk factor. Arch Dis Child. 1999;80:433–7.CrossRefPubMedPubMedCentral Van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in South Africa: burden and risk factor. Arch Dis Child. 1999;80:433–7.CrossRefPubMedPubMedCentral
3.
go back to reference Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392–402.PubMed Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392–402.PubMed
4.
go back to reference Smith S, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr. 1997;131:16–26.CrossRefPubMed Smith S, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr. 1997;131:16–26.CrossRefPubMed
5.
go back to reference Rieder HL. Interventions for tuberculosis control and elimination. Paris: International Union Against Tuberculosis and Lung Diseases; 2002. Rieder HL. Interventions for tuberculosis control and elimination. Paris: International Union Against Tuberculosis and Lung Diseases; 2002.
6.
go back to reference World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. 2012. WHO/HTM/TB/2012.9. World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. 2012. WHO/HTM/TB/2012.9.
7.
go back to reference Nardell EA, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings? N Engl J Med. 2011;365:79–81.CrossRefPubMed Nardell EA, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings? N Engl J Med. 2011;365:79–81.CrossRefPubMed
8.
go back to reference Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S, PACTG 1041 Team. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2009;12:225–7. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S, PACTG 1041 Team. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2009;12:225–7.
9.
go back to reference Mount FW, Ferebee SH. The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis. Am Rev Respir Dis. 1962;85:821–7.PubMed Mount FW, Ferebee SH. The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis. Am Rev Respir Dis. 1962;85:821–7.PubMed
10.
go back to reference Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis. 1962;85:490–510.PubMed Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis. 1962;85:490–510.PubMed
11.
go back to reference Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2:CD001363. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2:CD001363.
14.
go back to reference Jaganath D, Zalwango S, Okware B, Nsereko M, Kisingo H, Malone L, et al. Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis. 57(12):1685–92. Jaganath D, Zalwango S, Okware B, Nsereko M, Kisingo H, Malone L, et al. Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis. 57(12):1685–92.
15.
go back to reference The Ministry of Public health and sanitation, Kenya, Division of Leprosy, Tuberculosis, and lung Diseases Guidelines on management of Leprosy and tuberculosis: Diagnosis of Tuberculosis in Children. 2010. The Ministry of Public health and sanitation, Kenya,  Division of Leprosy, Tuberculosis, and lung Diseases Guidelines on management of Leprosy and tuberculosis: Diagnosis of Tuberculosis in Children. 2010.
19.
go back to reference Cohn DL, El-Sadr WM. Treatment of latent tuberculosis infection. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, Inc.; 2000. Cohn DL, El-Sadr WM. Treatment of latent tuberculosis infection. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, Inc.; 2000.
20.
go back to reference Hesseling AC, et al. The clinical features and outcome of confirmed tuberculosis (TB) in human immunodeficiency virus (HIV) infected children. Int J Tuberc Lung Dis. 2002;6(Suppl. 1):S181. Hesseling AC, et al. The clinical features and outcome of confirmed tuberculosis (TB) in human immunodeficiency virus (HIV) infected children. Int J Tuberc Lung Dis. 2002;6(Suppl. 1):S181.
21.
go back to reference Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomized controlled trial. BMJ. 2007;334:136–42.CrossRefPubMed Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomized controlled trial. BMJ. 2007;334:136–42.CrossRefPubMed
23.
go back to reference Martinson NA, Barnes GL, Moulton HL, Masandiwa R, Hausler H, Ram M, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011;365:79–81.CrossRef Martinson NA, Barnes GL, Moulton HL, Masandiwa R, Hausler H, Ram M, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011;365:79–81.CrossRef
24.
go back to reference Simon Schaaf H, Alimuddin Zuml. Human host factors which determine vulerability. In: Tuberculosis E-Book: A Comprehensive Clinical Reference, Elsevier Health Sciences, 24 Mar 2009. Simon Schaaf H,  Alimuddin Zuml. Human host factors which determine vulerability. In: Tuberculosis E-Book: A Comprehensive Clinical Reference, Elsevier Health Sciences, 24 Mar 2009.
25.
go back to reference Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a south African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2008;48(1):108–14.CrossRef Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a south African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2008;48(1):108–14.CrossRef
26.
go back to reference Garay JE. Clinical presentation of pulmonary tuberculosis in under 10s and differences in AIDS-related cases: a cohort study of 115 patients. Trop Dr. 1997;27:139–42. Garay JE. Clinical presentation of pulmonary tuberculosis in under 10s and differences in AIDS-related cases: a cohort study of 115 patients. Trop Dr. 1997;27:139–42.
27.
go back to reference Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a US public health service cooperative surveillance study. Am Rev Respir Dis. 1978;117:991–1001.PubMed Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a US public health service cooperative surveillance study. Am Rev Respir Dis. 1978;117:991–1001.PubMed
28.
go back to reference International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventative therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555–64.PubMedCentral International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventative therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555–64.PubMedCentral
29.
go back to reference Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238.CrossRefPubMedPubMedCentral Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238.CrossRefPubMedPubMedCentral
30.
go back to reference Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106.PubMed Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106.PubMed
31.
go back to reference Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006;91(9):762–5.CrossRefPubMedPubMedCentral Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006;91(9):762–5.CrossRefPubMedPubMedCentral
32.
go back to reference Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, et al. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis. 2006;6:97.CrossRefPubMedPubMedCentral Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, et al. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis. 2006;6:97.CrossRefPubMedPubMedCentral
33.
go back to reference van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10(1):13–8.PubMed van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10(1):13–8.PubMed
34.
go back to reference Steele RG, Anderson B, Rindel B, Dreyer ML, Perrin K, Christensen R, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13(5):617–29.CrossRefPubMed Steele RG, Anderson B, Rindel B, Dreyer ML, Perrin K, Christensen R, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13(5):617–29.CrossRefPubMed
35.
go back to reference Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79–87.CrossRefPubMedPubMedCentral Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79–87.CrossRefPubMedPubMedCentral
37.
go back to reference Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.CrossRefPubMed
38.
go back to reference Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–91.CrossRefPubMed
39.
go back to reference Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low- income and middle-income countries: a systematic review and meta- analysis. Lancet Infect Dis. 2008;8:359–68.CrossRefPubMed Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low- income and middle-income countries: a systematic review and meta- analysis. Lancet Infect Dis. 2008;8:359–68.CrossRefPubMed
40.
go back to reference Assefa D, Klinkenberg E, Yosef G. Cross sectional study evaluating routine contact investigation in Addis Ababa, Ethiopia: a missed opportunity to prevent tuberculosis in children. PLoS One. 2015;10(6):e0129135. Published online 2015 Jun 17. doi: 10.1371/journal.pone.0129135. PMCID: PMC4470906CrossRefPubMedPubMedCentral Assefa D, Klinkenberg E, Yosef G. Cross sectional study evaluating routine contact investigation in Addis Ababa, Ethiopia: a missed opportunity to prevent tuberculosis in children. PLoS One. 2015;10(6):e0129135. Published online 2015 Jun 17. doi: 10.1371/journal.pone.0129135. PMCID: PMC4470906CrossRefPubMedPubMedCentral
41.
go back to reference World Health Organization. Guidelines for intensive tuberculosis case finding and Isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO; 2011. World Health Organization. Guidelines for intensive tuberculosis case finding and Isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO; 2011.
Metadata
Title
Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya – a cohort study
Authors
Florence Nafula Okwara
John Paul Oyore
Fred Nabwire Were
Samson Gwer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2719-8

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.